A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice.
about
Influential Factors and Synergies for Radiation-Gene Therapy on CancerSynthetic therapeutic gene circuits in mammalian cellsSpatial and functional heterogeneities shape collective behavior of tumor-immune networksA programmable synthetic lineage-control network that differentiates human IPSCs into glucose-sensitive insulin-secreting beta-like cellsOsteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.Gut hormones such as amylin and GLP-1 in the control of eating and energy expenditure.Antagonistic control of a dual-input mammalian gene switch by food additives.A designer cell-based histamine-specific human allergy profiler.Optical control of insulin release using a photoswitchable sulfonylureaMind-controlled transgene expression by a wireless-powered optogenetic designer cell implant.Synthetic biology for therapeutic applications.Mapping network motif tunability and robustness in the design of synthetic signaling circuits.Cosmetics-triggered percutaneous remote control of transgene expression in mice.Synthetic gene network restoring endogenous pituitary-thyroid feedback control in experimental Graves' disease.Mini-review: Obesity in Caribbean YouthA synthetic biology-based device prevents liver injury in miceLow osteocalcin level is a risk factor for impaired glucose metabolism in a Chinese male populationSynthetic biology: applying biological circuits beyond novel therapies.A Synthetic-Biology-Inspired Therapeutic Strategy for Targeting and Treating Hepatogenous Diabetes.A Synthetic Mammalian Therapeutic Gene Circuit for Sensing and Suppressing Inflammation.Two-Way Chemical Communication between Artificial and Natural Cells.Synthetic Biology-The Synthesis of Biology.Engineering Gene Circuits for Mammalian Cell-Based Applications.Engineering cell-based therapies to interface robustly with host physiology.Engineering of synthetic gene circuits for (re-)balancing physiological processes in chronic diseases.Human whole-blood culture system for ex vivo characterization of designer-cell function.Synthetic biosensors for precise gene control and real-time monitoring of metabolitesEngineering Mammalian Designer Cells for the Treatment of Metabolic Diseases.Amylin - Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity.Bottom-up approaches in synthetic biology and biomaterials for tissue engineering applications.Designer cells programming quorum-sensing interference with microbes.Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson's disease treatment.A synthetic free fatty acid-regulated transgene switch in mammalian cells and mice
P2860
Q26771237-BF5A62D1-B598-44C6-A558-8B2CC33988C2Q26826954-569CCA50-754E-41C9-83AF-F617FA8832C5Q27319519-3339F0D3-08AF-4CBF-A8EB-BC2CCF10146AQ27320218-D0A52CF7-BBB9-4257-9B3F-3CB18D2BC02EQ33766277-DBD067DB-8839-465C-BCFF-BBC147EC5FF1Q33838133-9C510DF2-DB53-4A5B-9D9E-1FEFC846FD59Q34044270-B31F2668-1FA3-4EAB-99AF-81323E66FD36Q34086352-B8AC89C3-CCAF-46BB-BA49-25DAA9DBA4D4Q34397447-D0BF219E-E054-41FB-B8D0-A58B0333B0EAQ34563731-47D5011A-E00A-4727-9045-43CC3B4FEBC3Q35057524-6CA04FBE-8AA2-4512-A325-FE1437FD753DQ35123862-701A8797-F4F3-4E56-A4F3-0EC2B61E3373Q35961864-A313BA31-1876-4C9A-9216-78CFA3A74D22Q36563367-DC078C87-014D-4B83-A9C6-DC1A43FD714EQ36607983-BD0301E8-CE60-4946-9DEA-DFCE9FA46ED8Q37023678-1302A1FD-F27F-4C87-A50C-DE982A1E69E9Q37060844-ADC7C8DA-2C53-46D6-B04F-0F29CB35349FQ38679815-AE0D5385-E9AA-4626-9F13-8A4BF47D1315Q38718299-ED7128C6-A0C7-4169-9278-D44E07AC1947Q38719153-CFEBE634-1E6B-4E56-8E51-B82432A211D6Q38747821-3B8CFC38-D452-4CAB-8DDE-E79C1A91A9A0Q38784006-16BBEFD8-7694-47CE-9C13-AC68C3BB64DFQ38837855-1444CEA4-727C-49C8-9794-2BC7D9C9D2AAQ38856242-E73446A4-8E55-46A4-ABE8-AFA504331384Q38876131-439B02D9-407B-4C6D-AF85-62AECE7DAF73Q38966344-FBE1C63B-C1B4-41EA-B267-7550BBF68890Q41874589-E882D436-8783-4D7E-88A8-47ECF158DA7FQ47342408-098D981C-FD52-4C09-8E7C-EAC63DA76478Q47371506-B0A62DBE-8A53-4D3A-A7C0-6EBD7075506DQ52649385-4DCE056D-479F-4066-BA4E-7B37EBABF353Q54936236-1B23C76D-B259-4619-B490-DA274DC7F9E9Q54958949-39A02B87-7C98-4EF8-96DA-47731752D572Q57157379-54845886-A909-44B5-918E-DFB182C70278
P2860
A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice.
@en
A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice.
@nl
type
label
A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice.
@en
A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice.
@nl
prefLabel
A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice.
@en
A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice.
@nl
P2860
P356
P1476
A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice.
@en
P2093
Ghislaine Charpin-El-Hamri
Katrin Rössger
P2860
P2888
P356
10.1038/NCOMMS3825
P407
P577
2013-01-01T00:00:00Z